DE60201134D1 - Nicotinhaltige transdermale Darreichungsform zur Raucherentwöhnung - Google Patents

Nicotinhaltige transdermale Darreichungsform zur Raucherentwöhnung

Info

Publication number
DE60201134D1
DE60201134D1 DE60201134T DE60201134T DE60201134D1 DE 60201134 D1 DE60201134 D1 DE 60201134D1 DE 60201134 T DE60201134 T DE 60201134T DE 60201134 T DE60201134 T DE 60201134T DE 60201134 D1 DE60201134 D1 DE 60201134D1
Authority
DE
Germany
Prior art keywords
nicotine
dosage form
smoking cessation
transdermal dosage
containing transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60201134T
Other languages
English (en)
Other versions
DE60201134T2 (de
Inventor
Izhak Blank
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE60201134D1 publication Critical patent/DE60201134D1/de
Application granted granted Critical
Publication of DE60201134T2 publication Critical patent/DE60201134T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60201134T 2001-01-12 2002-01-09 Zusammenstetzung zur transdermalen Abgabe von Nikotin zum Einstellen des Rauchens Expired - Lifetime DE60201134T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/760,203 US6479076B2 (en) 2001-01-12 2001-01-12 Nicotine delivery compositions
US760203 2001-01-12

Publications (2)

Publication Number Publication Date
DE60201134D1 true DE60201134D1 (de) 2004-10-14
DE60201134T2 DE60201134T2 (de) 2005-10-13

Family

ID=25058416

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60201134T Expired - Lifetime DE60201134T2 (de) 2001-01-12 2002-01-09 Zusammenstetzung zur transdermalen Abgabe von Nikotin zum Einstellen des Rauchens

Country Status (3)

Country Link
US (1) US6479076B2 (de)
EP (1) EP1222923B1 (de)
DE (1) DE60201134T2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
ATE485837T1 (de) * 2000-08-03 2010-11-15 Antares Pharma Ipl Ag Zusammensetzung zur transdermalen und/oder transmukosalen verabreichung von wirkstoffen, die ausreichende therapeutische spiegel garantiert
DE10108387A1 (de) * 2001-02-21 2002-08-29 Basf Ag Kosmetisches oder pharmazeutisches Mittel
FR2821270B1 (fr) * 2001-02-26 2003-06-13 Columbus Utilisation de nicotine libre pour la fabrication d'une composition anti-cellulitique
WO2003049552A2 (en) * 2001-12-10 2003-06-19 Joseph Robert Knight Beverage treated with nicotine
US20060105023A1 (en) * 2001-12-10 2006-05-18 Knight Joseph R Treatment of neurological disorders with nicotine
BRPI0412752B8 (pt) * 2003-07-24 2021-05-25 Glaxosmithkline Llc composição de filme de dissolução oral
US7387788B1 (en) 2003-10-10 2008-06-17 Antares Pharma Ipl Ag Pharmaceutical compositions of nicotine and methods of use thereof
NZ546106A (en) * 2003-10-10 2008-10-31 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
BRPI0415741B1 (pt) 2003-11-07 2013-07-23 composições de tabaco e métodos de fabricação de uma composição de tabaco
US7425340B2 (en) 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
US7766018B2 (en) * 2004-09-30 2010-08-03 Smoke-Break, Inc. Device and composition for reducing the incidence of tobacco smoking
US8067399B2 (en) 2005-05-27 2011-11-29 Antares Pharma Ipl Ag Method and apparatus for transdermal or transmucosal application of testosterone
KR100699582B1 (ko) 2005-07-11 2007-03-23 삼성전기주식회사 출력 버퍼회로
US20070134169A1 (en) * 2005-12-11 2007-06-14 Rabinoff Michael D Methods for smoking cessation or alcohol cessation or other addiction cessation
CN101426475A (zh) 2006-04-21 2009-05-06 安塔雷斯制药Ipl股份公司 使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
WO2008012071A2 (en) * 2006-07-24 2008-01-31 Antares Pharma Ipl Ag Pharmaceutical compositions of nicotine and methods of use thereof
WO2008103818A1 (en) * 2007-02-21 2008-08-28 University Of Louisville Research Foundation Therapeutic cotinine compositions
US20080287507A1 (en) * 2007-05-16 2008-11-20 John Hedenstrom Nicotine containing toiletry waters
CL2008003507A1 (es) * 2007-11-26 2009-11-27 Neuroderm Ltd Composicion farmaceutica que comprende nicotina y un inhibidor de la desensibilizacion del receptor de acetilcolina nicotinico (nachr) opipramol; kit farmaceutico; dispositivo medico; y uso para tratar una enfermedad o trastorno del sistema nervioso central o periferico.
US20100256215A1 (en) * 2009-04-02 2010-10-07 Silver Eagle Labs Nv, Llc Menthol-Melatonin Dissolving Film
US20100256197A1 (en) * 2009-04-02 2010-10-07 Silver Eagle Labs Nv, Llc Nicotine Dissolving Film With Or Without Menthol
WO2015068058A1 (en) 2013-11-06 2015-05-14 Rk Technology & Investments Pte. Ltd. Tobacco free 'niconuts'and the process thereof
DE102014000200A1 (de) * 2014-01-03 2015-07-09 Michael Horstmann Transdermales Therapeutisches System
DE102017104026A1 (de) 2017-02-27 2018-08-30 Lts Lohmann Therapie-Systeme Ag Nicotin enthaltendes transparentes transdermales therapeutisches System
CN110755367B (zh) * 2019-10-11 2022-04-26 首都儿科研究所附属儿童医院 一种含有两亲性聚合物的血管瘤凝胶及其制备方法
LU101520B1 (en) 2019-12-02 2021-06-07 Herrera Arturo Solis (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a homogeneous, viscous, semi-solid topical medication and topical medication

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2776924A (en) 1954-02-05 1957-01-08 Coty Inc Composition of matter containing polyvinylpyrrolidone and a fatty carrier
US3275611A (en) * 1960-12-30 1966-09-27 Monsanto Co Process for polymerizing unsaturated monomers with a catalyst comprising an organoboron compound, a peroxygen compound and an amine
BE638231A (de) 1962-03-16
US3214338A (en) 1964-07-31 1965-10-26 Ehrlich Joseph Ronald Medicament releasing film-forming ointments and process of making
DE1467792A1 (de) 1965-05-21 1968-12-12 Brunnengraeber & Co Gmbh Dr Ch Sprengmittel fuer pharmazeutische Presslinge
FR2047874A6 (de) 1969-06-10 1971-03-19 Nouvel Lucien
DE2200778B2 (de) 1971-01-13 1974-04-18 Sandoz Ag, Basel (Schweiz) Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen
US3972995A (en) 1975-04-14 1976-08-03 American Home Products Corporation Dosage form
DE2634004B2 (de) 1976-07-29 1978-08-10 Bernhard Dr. 8000 Muenchen Lippold Verfahren zur Beschleunigung der Auflösung und Verbesserung der Löslichkeit von schlechtlöslichen zur peroralen Verabreichung bestimmten Arzneistoffen
US4210633A (en) 1978-10-20 1980-07-01 Eli Lilly And Company Flurandrenolide film formulation
AU563054B2 (en) * 1984-10-24 1987-06-25 Sekisui Kagaku Kogyo Kabushiki Kaisha Percutaneous tape of isdn
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
JPH02196714A (ja) * 1989-01-26 1990-08-03 Sekisui Chem Co Ltd 経皮吸収貼付剤
US4908213A (en) * 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine
EP0409383B1 (de) * 1989-07-21 1994-04-06 Izhak Blank Östradiol enthaltende Mittel und Verfahren zur topischen Anwendung
US5232703A (en) 1989-07-21 1993-08-03 Izhak Blank Estradiol compositions and methods for topical application
FR2699406B1 (fr) * 1992-12-21 1995-03-10 Commissariat Energie Atomique Films à base de copolymères, leurs applications dans des systèmes transdermiques et leurs procédés de préparation.
EP0781122B1 (de) * 1994-09-14 2000-07-05 Minnesota Mining And Manufacturing Company Matrix für transdermale wirkstofffreisetzung
FR2732223B1 (fr) * 1995-03-30 1997-06-13 Sanofi Sa Composition pharmaceutique pour administration transdermique
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
NZ332033A (en) * 1996-03-25 1999-09-29 Lohmann Therapie Syst Lts Transdermal therapeutic system (tts) with small application-area thickness and great flexibility, and production process
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
DE19719187A1 (de) * 1997-05-07 1998-11-12 Basf Ag Verwendung von Copolymerisaten des N-Vinyl-pyrrolidons in Zubereitungen wasserunlöslicher Stoffe
US20020110585A1 (en) * 1999-11-30 2002-08-15 Godbey Kristin J. Patch therapeutic agent delivery device having texturized backing
AU3104301A (en) * 2000-01-20 2001-07-31 Noven Pharmaceuticals, Inc. Compositions and methods to effect the release profile in the transdermal administration of active agents

Also Published As

Publication number Publication date
US20020131993A1 (en) 2002-09-19
EP1222923B1 (de) 2004-09-08
US6479076B2 (en) 2002-11-12
DE60201134T2 (de) 2005-10-13
EP1222923A1 (de) 2002-07-17

Similar Documents

Publication Publication Date Title
DE60201134D1 (de) Nicotinhaltige transdermale Darreichungsform zur Raucherentwöhnung
DK1267650T3 (da) Tobakbehandling
DE60225544D1 (de) Rauchloses tabakerzeugnis
DE60220661D1 (de) Transdermales pflaster zur verabreichung von fentanyl
NO20030627L (no) Hydrogel-drevet medikament doseringsform
NO20054682D0 (no) Sikker transdermal doseringsform
ATE449599T1 (de) Zusammensetzung zur transdermalen verabreichung von fentanyl
ATE258928T1 (de) Respiratorisches syncytialvirus replikation inhibitoren
EP1372392A4 (de) Nikotinhaltige orale arzneiform
ATE259796T1 (de) Respiratorisches syncytialvirus replikation inhibitoren
HK1084590A1 (en) Pharmaceutical composition for transdermal or transmucosal administration
ATE527901T1 (de) Zigarettenfilter
NO20055143D0 (no) Doseringsformer innbefattende AG013736
ATE402167T1 (de) 4-tetrazolyl-4-phenylpiperidinderivate zur schmerzbehandlung
DK1535524T3 (da) Filter til rygning
ATE269324T1 (de) Hydroxyphenyl-piperidin-4-ylidene-methyl- benzamidderivate zur schmerzbekämpfung
DE50102481D1 (de) Transdermale oder transmucosale darreichungsformen mit einer nicotinhaltigen wirkstoffkombination zur raucherentwöhnung
AU3240402A (en) Compounds and methods for promoting smoking cessation
DE60111520D1 (de) Hydroxyphenyl-piperazinyl-methyl-benzamid-derivate zur schmerzbehandlung
DE60109032D1 (de) Chinolinyl-piperidin-4-yliden-methyl-benzamid-derivate zur schmerzbekämpfung
AU6293101A (en) Method of promoting smoking cessation
ATE423549T1 (de) Injizierbare darreichungsform von flupirtin
NO20043633L (no) Oral doseringsform for kontrollert medikamentfrigivning
DE10393818D2 (de) Zigarettenschachtel
DK1404341T3 (da) Kombination af aktive substanser til farmakologisk terapi af nikotinafhængighed

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: WALLINGER RICKER SCHLOTTER FOERSTL, 80331 MUENCHEN